These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32895164)

  • 1. [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis].
    Fan Y; He R; Zou L; Meng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1062-1065. PubMed ID: 32895164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis.
    Hamai K; Iwamoto H; Ishikawa N; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N; Kohno N
    Dis Markers; 2016; 2016():4759040. PubMed ID: 27293304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
    Xue M; Guo Z; Cai C; Sun B; Wang H
    Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in idiopathic pulmonary fibrosis.
    Drakopanagiotakis F; Wujak L; Wygrecka M; Markart P
    Matrix Biol; 2018 Aug; 68-69():404-421. PubMed ID: 29408012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis.
    Song JW; Do KH; Jang SJ; Colby TV; Han S; Kim DS
    Chest; 2013 May; 143(5):1422-1429. PubMed ID: 23715088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
    Oldham JM; Ma SF; Martinez FJ; Anstrom KJ; Raghu G; Schwartz DA; Valenzi E; Witt L; Lee C; Vij R; Huang Y; Strek ME; Noth I;
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1475-82. PubMed ID: 26331942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of molecular biomarkers in idiopathic pulmonary fibrosis: A mini review.
    Chiba H; Otsuka M; Takahashi H
    Respir Investig; 2018 Sep; 56(5):384-391. PubMed ID: 30030108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study.
    Majewski S; Szewczyk K; Żal A; Białas AJ; Miłkowska-Dymanowska J; Piotrowski WJ
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
    Tomos I; Roussis I; Matthaiou AM; Dimakou K
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese.
    Isshiki T; Koyama K; Homma S; Sakamoto S; Yamasaki A; Shimizu H; Miyoshi S; Nakamura Y; Kishi K
    Sci Rep; 2021 Aug; 11(1):16250. PubMed ID: 34376770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
    Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
    BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood biomarkers in idiopathic pulmonary fibrosis.
    Vij R; Noth I
    Transl Res; 2012 Apr; 159(4):218-27. PubMed ID: 22424426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis.
    Wang Q; Xie Z; Wan N; Yang L; Jin Z; Jin F; Huang Z; Chen M; Wang H; Feng J
    Chin Med J (Engl); 2023 Jun; 136(11):1278-1290. PubMed ID: 37130223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis.
    Inchingolo R; Varone F; Sgalla G; Richeldi L
    Expert Rev Respir Med; 2019 Jan; 13(1):39-51. PubMed ID: 30526140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.